| abstract |
The invention relates to a composition containing as active ingredient ectoine, hydroxyectoine and / or salts, esters or amides of these compounds for the treatment and / or prophylaxis of diseases of the eye, which are associated with a disorder of the tear film. This may in particular be a keratoconjunctivitis sicca. It has surprisingly been found that these compounds are able to prevent tearing of the outer lipid layer of the tear film, so that an undesirably rapid evaporation of the tear fluid is avoided. |